Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
349.01M | 330.48M | 271.82M | 232.34M | 191.91M | 151.53M | Gross Profit |
263.03M | 247.96M | 194.37M | 167.22M | 139.25M | 111.24M | EBIT |
13.65M | 7.17M | -15.35M | -41.07M | -53.49M | -15.44M | EBITDA |
17.86M | 12.55M | -10.66M | -30.12M | -52.25M | -14.38M | Net Income Common Stockholders |
-23.93M | -29.09M | -21.73M | -41.63M | -35.22M | -17.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
351.80M | 290.90M | 226.88M | 229.81M | 270.63M | 70.10M | Total Assets |
598.85M | 519.05M | 442.58M | 415.53M | 388.74M | 169.05M | Total Debt |
11.65M | 16.53M | 14.72M | 16.74M | 0.00 | 0.00 | Net Debt |
-339.83M | -274.20M | -208.44M | -210.45M | -268.22M | -69.11M | Total Liabilities |
237.40M | 248.11M | 217.74M | 172.38M | 133.17M | 148.87M | Stockholders Equity |
359.50M | 270.95M | 210.60M | 229.15M | 250.35M | 17.13M |
Cash Flow | Free Cash Flow | ||||
99.87M | 85.85M | 31.17M | -6.24M | 2.57M | 18.10M | Operating Cash Flow |
105.88M | 88.89M | 34.69M | -774.00K | 5.03M | 19.12M | Investing Cash Flow |
-16.49M | -2.60M | -5.65M | -21.45M | -3.38M | 1.37M | Financing Cash Flow |
73.61M | -15.54M | -33.67M | -17.15M | 198.62M | 35.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $4.09B | ― | -0.71% | ― | 34.37% | 95.80% | |
68 Neutral | $3.20B | 28.86 | 7.87% | ― | 5.03% | ― | |
66 Neutral | $2.57B | 24.52 | -41.63% | ― | 13.21% | 109.61% | |
65 Neutral | $3.82B | ― | -8.39% | ― | 21.70% | -67.95% | |
64 Neutral | $1.79B | ― | -3.09% | ― | -1.96% | 19.43% | |
62 Neutral | $11.97B | 10.08 | -7.46% | 2.96% | 7.37% | -8.22% | |
61 Neutral | $3.79B | 8.73 | -8.85% | ― | -14.03% | -167.03% |
On June 9, 2025, AvePoint, Inc. announced the redemption of all its outstanding public warrants to purchase shares of its common stock, originally issued under a 2019 Warrant Agreement. The redemption is set for July 9, 2025, at a price of $0.01 per warrant, with unexercised warrants becoming void post-redemption. This move reflects AvePoint’s strategic decision to streamline its equity structure, potentially impacting warrant holders who must decide whether to exercise their warrants at $11.50 per share before the deadline.
The most recent analyst rating on (AVPT) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on AvePoint stock, see the AVPT Stock Forecast page.